Mirum Pharmaceuticals, Inc.
MIRM
$102.19
-$9.21-8.26%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -798.84M | -23.36M | -41.42M | -58.56M | -77.34M |
| Total Depreciation and Amortization | 25.07M | 24.24M | 24.23M | 24.22M | 24.02M |
| Total Amortization of Deferred Charges | 1.76M | 1.74M | 1.72M | 1.70M | 1.68M |
| Total Other Non-Cash Items | 507.24M | 72.92M | 67.56M | 62.41M | 57.44M |
| Change in Net Operating Assets | 93.80M | -19.72M | -7.39M | -20.77M | -12.65M |
| Cash from Operations | -170.98M | 55.83M | 44.69M | 9.00M | -6.85M |
| Capital Expenditure | -1.58M | -954.00K | -374.00K | -368.00K | -1.02M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -17.81M | -23.00M | -23.95M | -39.76M | -105.23M |
| Cash from Investing | -19.39M | -23.95M | -24.32M | -40.13M | -106.25M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 312.46M | 40.14M | 36.48M | 24.25M | 22.85M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -8.60M | -- | -- | -- | -- |
| Cash from Financing | 303.86M | 40.14M | 36.48M | 24.25M | 22.85M |
| Foreign Exchange rate Adjustments | 895.00K | 3.22M | 2.25M | 1.99M | -355.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 114.39M | 75.24M | 59.11M | -4.89M | -90.60M |